Continuous Infusion of Ketamine in Mechanically Ventilated Patients with SARS-CoV-2.

Brian PhanAfua AgyemangWalter Klein Suman B Thapamagar

Published in: Critical care research and practice (2024)

In patients with SARS-CoV-2 on MV, there was no difference in the vasopressor requirement in patients receiving ketamine compared to propofol. Nevertheless, the use of ketamine was associated with higher MAP, reductions in CRP in select timepoints, and overall lower opioid requirements.

Keyphrases

sars cov
pain management
respiratory syndrome coronavirus
chronic pain
intensive care unit
low dose